DCGO 10-Q: SEC filing
DocGo Inc.
Filed with the SEC on · accession 0001628280-26-072270
DCGO filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +2.8% by the first close after the filing.
Summary of the filing
DocGo Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing a subsequent event involving a secured debt financing related to Hicuity Health, Inc. under a Perceptive Credit Agreement.
Key details
How DCGO stock reacted
Close before
$0.24
Nov 6, 2026
First close after
+2.78%
$0.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DCGO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DCGO?
Click hereFrequently asked questions
What did DCGO file with the SEC on Nov 9, 2026?
DCGO filed a 10-Q (SEC filing). DocGo Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing a subsequent event involving a secured debt financing related to Hicuity Health, Inc. under a Perceptive Credit Agreement.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did DCGO stock react to this filing?
DCGO closed at $0.24 before the filing and $0.25 on Nov 9, 2026 (+2.78%).
Other DCGO SEC filings
Get alerts when DCGO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days